| abstract |
Tripeptide compositions and methods for treating diabetes are provided. The present invention is directed to peptide compositions and methods of treating prediabetes, diabetes, obesity, hypertension and metabolic syndrome using the peptide compositions. The invention comprises administering to a patient an effective amount of a composition comprising at least one peptide consisting of the amino acid sequence GGL, GLG, LGL, LLG, LGG or GLL or a pharmaceutically acceptable salt of said peptide. Wherein said symptom is pre-diabetes, diabetes, obesity, hypertension, metabolic syndrome, poor glycemic control or decreased insulin secretion. [Selection] Figure 1 |